ATE290528T1 - Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure - Google Patents

Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure

Info

Publication number
ATE290528T1
ATE290528T1 AT02010234T AT02010234T ATE290528T1 AT E290528 T1 ATE290528 T1 AT E290528T1 AT 02010234 T AT02010234 T AT 02010234T AT 02010234 T AT02010234 T AT 02010234T AT E290528 T1 ATE290528 T1 AT E290528T1
Authority
AT
Austria
Prior art keywords
alpha
hydroxydiphenylmethyl
hydroxy
piperidinyl
butyl
Prior art date
Application number
AT02010234T
Other languages
English (en)
Inventor
Graziano Castaldi
Giuseppe Barreca
Domenico Magrone
Original Assignee
Dipharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Spa filed Critical Dipharma Spa
Application granted granted Critical
Publication of ATE290528T1 publication Critical patent/ATE290528T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
AT02010234T 2001-05-17 2002-05-16 Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure ATE290528T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000260A ITRM20010260A1 (it) 2001-05-17 2001-05-17 Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz

Publications (1)

Publication Number Publication Date
ATE290528T1 true ATE290528T1 (de) 2005-03-15

Family

ID=11455529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02010234T ATE290528T1 (de) 2001-05-17 2002-05-16 Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure

Country Status (13)

Country Link
US (1) US6815549B2 (de)
EP (1) EP1260505B1 (de)
JP (1) JP2003026658A (de)
AT (1) ATE290528T1 (de)
CA (1) CA2386452A1 (de)
CZ (1) CZ295949B6 (de)
DE (1) DE60203142T2 (de)
ES (1) ES2237631T3 (de)
HU (1) HUP0201673A3 (de)
IT (1) ITRM20010260A1 (de)
PL (1) PL353977A1 (de)
PT (1) PT1260505E (de)
SI (1) SI1260505T1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044038A1 (en) * 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
EP1616861A3 (de) * 2004-06-15 2006-02-08 Dipharma S.p.A. Verfahren zur Herstellung von Keto-Verbindungen
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20070987A1 (it) 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
IT1395337B1 (it) * 2009-03-04 2012-09-14 Dipharma Francis Srl Procedimento per la preparazione di intermedi chetonici
ES2403130B1 (es) * 2010-06-15 2014-09-29 Chemelectiva S.R.L. Forma polimórfica de clorhidrato de fexofenadina, compuestos intermedios y procedimiento para su preparación
CN102079708B (zh) * 2011-02-11 2013-10-02 浙江启明药业有限公司 4-(4-卤丁酰基)-α,α-二甲基苯乙酸酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021156A1 (en) 1992-04-10 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives

Also Published As

Publication number Publication date
PT1260505E (pt) 2005-05-31
HUP0201673A3 (en) 2004-07-28
ITRM20010260A0 (it) 2001-05-17
HU0201673D0 (de) 2002-07-29
US6815549B2 (en) 2004-11-09
PL353977A1 (en) 2002-11-18
CZ20021726A3 (cs) 2003-01-15
EP1260505B1 (de) 2005-03-09
US20020198233A1 (en) 2002-12-26
JP2003026658A (ja) 2003-01-29
EP1260505A1 (de) 2002-11-27
ITRM20010260A1 (it) 2002-11-18
SI1260505T1 (en) 2005-06-30
DE60203142D1 (de) 2005-04-14
HUP0201673A2 (hu) 2003-02-28
CZ295949B6 (cs) 2005-12-14
ES2237631T3 (es) 2005-08-01
CA2386452A1 (en) 2002-11-17
DE60203142T2 (de) 2006-04-13

Similar Documents

Publication Publication Date Title
ATE220667T1 (de) Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
ATE290528T1 (de) Verfahren zur herstellung von 4-(1-hydroxy-4-(4- (hydroxydiphenylmethyl)-1-piperidinyl)-butyl)- alpha, alpha-dimethylphenylessigsäure
ATE440815T1 (de) Verfahren zur herstellung von dialkylcarbonaten
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE261953T1 (de) Verfahren zur herstellung von citalopram
ATE283841T1 (de) Verfahren zur herstellung von amlodipin- benzolsulfonat
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
ATE277015T1 (de) Verfahren zur herstellung von 1,4-dihydropyridine sowie in diesem verfahren verwendete verbindungen
DE50207455D1 (de) Verfahren ZUR HERSTELLUNG VON CARBONSÄURESALZEN
DE50204441D1 (de) Verfahren zur Herstellung von Salzen der Methallylsulfonsäure
ATE348810T1 (de) Verfahren zur herstellung von 2-aminomethyl- halogen-pyridinen
DE60217414D1 (de) Verfahren zur Herstellung von Alpha-Hydroxycarbonsäure Amiden
ATE496907T1 (de) Verfahren zur herstellung von cilostazol
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60312214D1 (de) Verfahren zur herstellung von(4e)-5-chloro-2-isopropyl-4-pentensäureester und optischaktivem isomer davon
DE60213998D1 (de) Verfahren zur herstellung von 2 oxocarbonsäureestern
ATE554068T1 (de) Verfahren zur herstellung von ketoverbindungen
ATE399757T1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
ATE330612T1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE231858T1 (de) Verfahren zur herstellung von 3-substituierten 4- phenyl-piperidin derivaten
ATE404559T1 (de) Verfahren zur herstellung von säuresalzen von gemifloxacin
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
ATE415389T1 (de) Verfahren zur herstellung von lercanipidin
WO2007049303A3 (en) An improved process for the preparation of highly pure fexofenadine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1260505

Country of ref document: EP

REN Ceased due to non-payment of the annual fee